unknown
Stage
About
2cureX develops IndiTreat®, a functional precision medicine diagnostic that cultures patient-derived 3D tumoroids to perform drug sensitivity testing and report individualized therapy responses to clinicians to guide cancer treatment decisions. The company aims to commercialize these tests through regulatory (IVDR) and reimbursement pathways for use in hospital labs.
Explore 2cureX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.